9 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 9 at 12:35 PMCAPR+4.87%LLY+1.97%
Capricor CFO Anthony Bergmann disposes of USD 732,158 in common sharesPUBT·Jun 29 at 08:30 PMCAPR+4.87%
Capricor Therapeutics (CAPR) Is Down 6.8% After Positive Five-Year HOPE-2 DMD Data And FDA UpdateSimplywall·Jun 27 at 06:56 PMCAPR+4.87%
What's Going On With Capricor Therapeutics Stock On Friday?benzinga_article·Jun 26 at 01:06 PMCAPR+4.87%
Capricor falls as FDA sets up AdCom meeting to review Duchenne therapybusinessinsider·Jun 26 at 09:15 AMCAPR+4.87%
Capricor says deramiocel meets primary endpoint in HOPE-3 Phase 3 Duchenne muscular dystrophy trialPUBT·Jun 26 at 08:05 AMCAPR+4.87%
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy | CAPR Stock NewsStockTitan·Jun 26 at 01:02 AMCAPR+4.87%
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference | CAPR Stock NewsStockTitan·Jun 26 at 12:05 AMCAPR+4.87%
